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Research
Particulate matter (PM) ≤ 2.5 µm in aero-
dynamic diameter (PM2.5) is associated with 
an increased risk for cardiovascular (CV) mor-
bidity and mortality, even within the same 
day of exposure (Peters et al. 2001). PM2.5-
induced endothelial dysfunction and elevated 
blood pressure (BP) may be playing important 
causative roles (Brook 2008). Indeed, higher 
levels of ambient PM2.5 have been associated 
with blunted brachial flow–mediated dilata-
tion (FMD) and elevated BP (Auchincloss 
et al. 2008; Chuang et al. 2005; Dales et al. 
2007; Dvonch et al. 2009; Ebelt et al. 2005; 
Langrish et al. 2009; Liu et al. 2009; O’Neill 
et al. 2005; Rundell et al. 2007; Schneider 
et al. 2008; Zanobetti et al. 2004). However, 
most studies have examined these outcomes 
only ≥ 1 days after relatively prolonged expo-
sures (e.g., 24- to 72-hr mean PM2.5 levels) 
(Brook and Rajagopalan 2009). Whether 
brief (e.g., hour-long) exposures to PM2.5 at 
commonly encountered present-day ambi-
ent levels can alter arterial hemo  dynamics 
and vascular function as rapidly as within the 
same day and the characteristics (e.g., mag-
nitude, consistency) of any such responses 
remain unclear. Because 2-hr-long exposure 
to very high particle levels under experimental 
conditions can elevate BP and impair FMD 
within hours (Brook et al. 2009), it is plau-
sible that PM2.5 at lower ambient levels may 
induce similar responses.
The relationship between personal expo-
sures and ambient PM2.5 mass concentrations 
can significantly vary among individuals, with 
personal levels potentially being more predic-
tive of health responses (Brook et al. 2010; 
Rodes et al. 2010). Exposure characterizations 
at the personal level thus advance our under-
standing of the complex relationships between 
pollution exposures and diseases (Weis et al. 
2005). The CV substudy of the Detroit 
Exposure Aerosol Research Study (DEARS) 
was designed to elucidate the air pollution 
components and time frames of exposure 
responsible for affecting several CV outcomes, 
including arterial hemodynamics [i.e., BP and 
heart rate (HR)] and vascular function. The 
initial results compared the effects associated 
with daily (24-hr) mean ambient PM2.5 expo-
sures assessed at personal versus community 
levels (Brook et al. 2010). In this analysis, we 
aimed to gain insight into the acute same-
day exposure–response relationships at a finer 
time-scale resolution. We explored the asso-
ciations between the CV outcomes, including 
BP, FMD, and HR, and changes in total per-
sonal PM2.5 exposure (TPE) measured each 
hour during routine daily activity throughout 
the preceding 24-hr period.
Materials and Methods
This study was approved by the institutional 
review boards of the University of Michigan 
and RTI International along with the human 
subjects–approving official of the U.S. 
Environmental Protection Agency. The main 
DEARS protocol has been described in more 
detail elsewhere (Williams 2005; Williams 
et al. 2009). All participants were non-
smokers living in a nonsmoking household, 
at least 18 years old, ambulatory, and capable 
of understanding the consent documenta-
tion. There were no exclusion criteria for race, 
occupation, sex, medications, or health status. 
In addition to community and residential 
PM2.5 site monitoring that occurred within 
six Detroit, Michigan, area neighborhoods 
during summer and winter periods over 
3 years (six total seasons), TPE was also meas-
ured for 5 consecutive days during winter 
and/or summer months using personal vest 
monitors for one study volunteer from each 
participating household. DEARS exposure 
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Ba c k g r o u n d: Levels of fine particulate matter [≤ 2.5 µm in aerodynamic diameter (PM2.5)] are 
associated with alterations in arterial hemodynamics and vascular function. However, the charac-
teristics of the same-day exposure–response relationships remain unclear.
oB j e c t i v e s: We aimed to explore the effects of personal PM2.5 exposures within the preceding 
24 hr on blood pressure (BP), heart rate (HR), brachial artery diameter (BAD), endothelial function 
[flow-mediated dilatation (FMD)], and nitroglycerin-mediated dilatation (NMD).
Me t h o d s : Fifty-one nonsmoking subjects had up to 5 consecutive days of 24-hr personal PM2.5 
monitoring and daily cardiovascular (CV) measurements during summer and/or winter periods. The 
associations between integrated hour-long total personal PM2.5 exposure (TPE) levels (continuous 
nephelometry among compliant subjects with low secondhand tobacco smoke exposures; n = 30) 
with the CV outcomes were assessed over a 24-hr period by linear mixed models.
re s u l t s: We observed the strongest associations (and smallest estimation errors) between HR and 
TPE recorded 1–10 hr before CV measurements. The associations were not pronounced for the 
other time lags (11–24 hr). The associations between TPE and FMD or BAD did not show as clear 
a temporal pattern. However, we found some suggestion of a negative association with FMD and a 
positive association with BAD related to TPE just before measurement (0–2 hr).
co n c l u s i o n s: Brief elevations in ambient TPE levels encountered during routine daily activity 
were associated with small increases in HR and trends toward conduit arterial vasodilatation and 
endothelial dysfunction within a few hours of exposure. These responses could reflect acute PM2.5-
induced autonomic imbalance and may factor in the associated rapid increase in CV risk among 
susceptible individuals.
key  w o r d s : endothelium, heart rate, particulate matter air pollution, personal expo-
sure monitoring, sympathetic nervous system. Environ Health Perspect 119:688–694 (2011). 
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study participants were invited without any 
restrictions to also participate in the CV sub-
study while it was occurring (during seasons 
2–6). Volunteers crossing over into the CV 
study underwent an additional visit, when 
written informed consent was obtained and 
the average of the second and third of three 
seated BP measurements was determined 
along with a fasting lipid profile and glucose 
(Cholestech LDX analyzer; Cholestech Corp., 
Hayward, CA, USA).
Exposure assessments. The primary PM2.5 
personal monitoring reported here was per-
formed using a modified personal DataRam 
nephelometer (model pDR-1200; Thermo 
Electron, Franklin, MA, USA). These devices 
are capable of the near-continuous active sam-
pling and analysis of PM in either an active or 
passive sampling mode. The device was oper-
ated in an active mode (30-sec data collec-
tion intervals) for DEARS so that a true size 
fractionation of airborne PM aerosol could be 
estimated over the course of each 24-hr moni-
toring period. Modification of the basic unit 
consisted of installation of an active PM2.5 
personal environmental monitor (PEM) size-
fractionating inlet upstream of the optical 
chamber. Williams et al. (2009) have previ-
ously described in detail the use and modifi-
cation of this monitor in DEARS. The basic 
personal nephelometer deployed here has been 
used to provide thousands of short-interval 
PM mass concentration measurements in 
human exposure longitudinal panel studies. 
We have previously reported on the operation 
and utility of the monitor for such purposes 
(Wallace et al. 2006) and their general com-
parability with filter-based (gravimetric) meas-
urements (Rea et al. 2001). He et al. (2010) 
have recently reported the successful use of a 
similar version of this personal nephelometer 
in characterizing PM2.5 influence of HR vari-
ability alterations in an adult cohort.
The personal nephelometer was one of a 
number of monitoring devices incorporated 
into an exposure monitoring vest that each 
study participant wore throughout each day. 
PM2.5 nephelometry was initiated on each 
monitoring day (Tuesday through Saturday) 
at a consistent time (0900 hours ± 2.5 hr). 
Each monitoring session represented a con-
tinuous 24-hr period of air collection using a 
lightweight nylon monitoring vest to secure 
the sampler’s inlet in the breathing zone of 
the participant (Williams et al. 2003, 2009). 
Participants were instructed to wear the vest at 
all times except for periods of sleeping, bath-
ing, and changing clothes, at which times the 
monitor was directed to be kept as close as 
possible to the subject (e.g., next to the bed at 
night). Quality of the nephelometric data col-
lected in the study was ensured through rigor-
ous quality assurance/quality control (QA/QC) 
procedures. In brief, each nephelometer was 
chamber calibrated immediately before each 
DEARS monitoring season using a challenge 
aerosol of PM2.5 size-fractionated ammonium 
nitrate, which was known to make up a sizable 
component of the Detroit air shed. In addition, 
each unit was audited once during the season 
for any response changes in its calibration as 
well as at the end of the 7-week study period. 
Daily audits of monitor flow rate and battery 
condition, among other parameters, were per-
formed. Audits of the units’ zero concentration 
response point (baseline) were performed using 
a HEPA-grade airstream. Study data were 
reviewed each day for completeness (length 
of successful monitor operation), impact of 
relative humidity (RH) on monitor response, 
and overall data acceptability criteria (moni-
tor response relative to changes in minute by 
minute data values). Wallace et al. (2006) have 
described in detail the procedures used here 
to determine overall data acceptance criteria. 
Because nephelometric response is known to 
be RH sensitive, continuous RH measure-
ments were taken simultaneously (Williams 
et al. 2009). These RH were then used to 
establish an algorithm to correct nephelometric 
response for such bias. A full description of this 
algorithm will be reported elsewhere. All data 
reported here were RH corrected.
The monitoring vest deployed here con-
tained continuous sensors that monitored 
how compliant participants were with wear-
ing it during the nonexclusion scenarios or 
time of day (e.g., sleeping, bathing). These 
sensors collected information on physical 
activity levels and body temperature among 
other parameters of the participant. These 
electronic data were then cross-checked with 
15-min interval time–activity diaries com-
pleted each day by the participant to note 
periods of reported sleeping, bathing, or per-
forming other activities resulting in the moni-
toring equipment not being worn. Findings 
from this review resulted in a level of general 
monitoring compliance for each monitor-
ing period. Only monitoring data from par-
ticipants meeting a prespecified conservative 
compliance rate of 60% were analyzed in this 
study, for reasons described elsewhere (Rodes 
et al. 2010; Williams et al. 2009).
Although all participants recruited into 
DEARS were self-reported to be nonsmokers 
living in nonsmoking households, each partici-
pant’s exposure to secondhand smoke (SHS) 
was also measured simultaneously with the 
nephelometric monitoring. These data were 
collected using another collocated PM2.5 PEM 
inlet also affixed to the monitoring vest. This 
inlet contained a 37-mm Teflon filter (Teflo; 
Gelman Science, Ann Arbor, MI, USA) for 
active (2 L/min) exposure monitoring. The 
subsequent filter samples were optically ana-
lyzed for a mass-based estimate of SHS using 
a technique previously described (Lawless et al. 
2004; Rodes et al. 2010; Williams et al. 2009). 
Only the results from subjects with a prede-
termined rate of < 1.5 µg/m3 of mean daily 
SHS exposure were included in this analysis to 
avoid its potential confounding effect on the 
CV outcomes as described elsewhere (Brook 
et al. 2010). Rodes et al. (2010) has provided 
a detailed examination of potential SHS 
impact on personal exposures in the DEARS; 
the threshold of 1.5 µg/m3 was employed to 
note such influence. The SHS threshold value 
used here results in a very conservative data 
  inclusion criteria.
The filter sample described above also 
provided the means to establish a filter-based 
gravi  metric estimate of personal PM2.5 expo-
sure that could be compared with the contin-
uous nephelometric response. This filter-based 
sampling technique and the actual monitor-
ing device used here have been used to col-
lect thousands of personal exposure samples. 
It provided for a 24-hr integrated estimate 
of PM2.5 personal exposure in DEARS, as 
described elsewhere (Brook et al. 2010; Rodes 
et al. 2010; Williams et al. 2009). Data from 
collocated personal monitoring of both sam-
plers from each personal monitoring event 
were then used poststudy to determine the 
level of agreement between the two tech-
niques (nephelometry and gravimetric). 
Nephelometric mass concentrations (micro-
grams per cubic meter) were highly corre-
lated with those from the filter-based sampler. 
Integration of the personal nephelometric data 
from each 24-hr monitoring period provided 
a single average concentration, which in turn 
was compared with the filter-based monitor-
ing, resulting in a mean coefficient of deter-
mination of R2 = 0.80 (range, 0.75–0.85) over 
the three DEARS monitoring periods (seasons 
4–6) reported here. This level of agreement 
was believed to indicate the high degree of 
QA/QC that was employed for the study, 
the use of the same size-fractioning inlet for 
both monitoring types, the use of a calibra-
tion aerosol (ammonium nitrate) similar to 
that encountered in Detroit, and correcting 
for RH bias among other factors.
All of the PM2.5 nephelometric data 
reported here represent TPE. No source cat-
egorization of the aerosol into its various com-
ponents (e.g., PM of ambient origin, PM of 
nonambient origin) is possible at this time. 
Nonambient sources would potentially include 
cooking aerosols and mobile source emissions, 
among others. Such sources often contrib-
ute 50% or more of the TPE (Wallace et al. 
2006). Future efforts will attempt to integrate 
observational survey data collected in DEARS 
and determine individual sources of short 
duration affecting the nephelometric response.
CV end points. CV study visits were per-
formed at the participant’s home for up to 
5 consecutive evenings, Tuesday through Brook et al.
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Saturday, between 1600 and 1900 hours. 
These visits took place on concurrent days 
while subjects wore the vest monitors. There 
were six CV outcomes: systolic and diastolic 
BP, HR, brachial artery diameter (BAD; indica-
tive of basal arterial tone), FMD, and nitro-
glycerin-mediated dilatation (NMD; indicative 
of smooth muscle function). Participants were 
instructed to maintain their daily routine, 
including taking all medications, but to fast 
for at least 4 hr before the scheduled visits and 
to avoid unusual physical activity. During each 
visit, subjects rested supine for 10 min before 
automated BP and HR measurement (Omron 
780 monitor; Omron Inc, Kyoto, Japan) that 
was obtained in triplicate with a 1-min lapse 
between meas  ures. The average of the second 
and third BP and HR recordings was used for 
analyses (Pickering et al. 2008).
BAD and FMD were next determined. 
Brachial images were obtained with a por-
table Terason 2000 ultrasound system with 
a 10.0-mHz linear array transducer with 
electrocardiogram-gated image acquisition 
(http://www.terason.com/; Teratech Corp., 
Burlington, MA, USA). Five minutes of upper 
arm occlusion using a rapidly deflating arm 
cuff was performed in order to determine 
FMD, which was defined as the mean percent 
increase in BAD above baseline diameter from 
between 50 and 70 sec after cuff deflation. 
Images were analyzed using semiautomated 
edge detection software (Vascular Research 
Tools; Medical Imaging Applications, LLC, 
Coralville, IA, USA). NMD was next deter-
mined as the percent dilatation of the BAD 
3 min after 0.4 mg of sublingual nitroglycerin. 
Detailed descriptions of the methods have been 
previously described and accord with guidelines 
(Brook et al. 2005), and the reproducibility of 
our testing is reported elsewhere (Brook et al. 
2009). Compared with the brachial FMD 
study technique performed in our controlled 
laboratory setting as described elsewhere, the 
only substantive methodological differences 
in this study are the lack of room temperature 
standardization and the fact that subjects fasted 
for only at least 4 hr before measurements.
Statistical assumptions and models. 
Integrated hour-long total PM2.5 exposures 
(i.e., TPE) during the preceding 24-hr period, 
calculated for each individual starting imme-
diately before the time of their CV outcome 
measurements, were determined from the 
vest continuous nephelometry data (i.e., 24 
individual hour-long periods from lag 0 to 
lag 23 hr), with lag 0 representing the time 
between 0 and 60 min before the CV out-
come measurement. Two subjects with three 
observation periods were removed from analy-
ses because > 25% of their hourly TPE levels 
during a day were negative (i.e., < 0 µg/m3), 
indicative of a systematic error in the vest 
monitoring system on that day, per study pro-
tocol. The associations for each hour-long TPE 
period were made for six prespecified outcome 
variables: systolic BP, diastolic BP, HR, BAD, 
FMD, and NMD. All of these CV outcomes 
were observed for 5 consecutive days for each 
season (winter vs. summer) within a subject.
The subjects were considered to be selected 
at random from a population of preselected 
neighborhoods per the design and methods of 
the main DEARS cohort, as described in more 
detail elsewhere (Williams 2005; Williams 
et al. 2009). Considering the possibility that 
within-subject errors were autocorrelated, a 
linear mixed model was employed because 
it was more appropriate when data were col-
lected over time on the same subjects (Shoukri 
and Chaudhary 2007; West et al. 2007). We 
thus assumed that the association between 
each of the responses evaluated and exposure 
to TPE is linear with an intercept varying at 
random over individuals, but the slope was 
assumed to be the same for all subjects. Several 
predictors of the response were included in 
the model as fixed effects: age, sex, race, body 
mass index (BMI), and ambient community-
level temperature (Temp). The relationship 
between these predictors and responses was 
assumed to be common to all subjects: 
 Y ij – β0 + β1Hk × PM2.5 + β2age  
    + β3sex + β4race + β5BMI  
    + β6Temp + αi + εij,  [1]
where Yij is the response, a CV outcome for 
subject i at study day j, and β1Hk × PM2.5 is 
the k-hr lag TPE before the health outcome 
measurement time. This model includes fixed 
effects associated with the subject-level cova-
riates (β-values), a random effect associated 
with the intercept for each subject (αi), and a 
residual associated with each observation (εij). 
The random effects by subject were assumed 
to be independently distributed across sub-
jects with a normal distribution αi ~ N(0, δ2). 
The within-subjects errors εij were assumed 
to be distributed εij ~ N(0, σ2Ri), where Ri 
was the variance–covariance matrix for the 
residuals. We also assumed that αi and εij 
were independent of each other.
The first-order autoregressive structure, 
denoted by AR(1), was explored for the cova-
riance Ri in the analysis, which implies that 
observations closer to each other in time 
exhibit higher correlation than do observations 
farther apart in time. The likelihood ratio test 
showed the AR(1) correlation structure did 
not improve the fit. Other available covariates, 
including season (i.e., winter vs. summer), 
neighborhood indictor, and the subject’s study 
day (e.g., first vs. second day of monitoring 
during the 5-day period), were not included 
in the final model because they did not pre-
dict responses individually or alter the signifi-
cance of any results. We could examine only 
a limited number of time periods simultane-
ously because of the relatively small number 
of repeated responses per subject (maximum 
of five per season). Complex distributed time 
lag models beyond those incorporating a few 
lag periods were therefore not analyzed, and 
also because of highly correlated dependent 
and independent variables were inappropriate 
models. Although the effects of several dif-
ferent moving averages of exposure duration 
were explored, a complete description of the 
time course of personal PM2.5 exposure was 
most thoroughly examined for the purposes of 
this exploratory analysis by using 24 multiple 
models, each with a single hourly time lag 
exposure measure. The analysis was performed 
by function “lme” (linear mixed-effects model) 
in R (version 2.8.1; R Project for Statistical 
Computing, Vienna, Austria). Statistical sig-
nificance was defined as p < 0.05.
Table 1. Subject characteristics in the vest compliance and low SHS subgroup (n = 30).
Factor
No. of 
  observations Mean ± SD Minimum Q1 Median Q3 Maximum
Age (years) 30 45.4 ± 14.3 22 33 46 54 73
Sex (%) 30
Female 25 83
Male 5 17
Race (%) 30
African American 13 43
Caucasian 16 53
American Indian 1 3
BMI (kg/m2) 30 29.9 ± 5.9 21.8 25.3 29.9 33.0 48.2
SBP (mmHg) 100 123.0 ± 16.5 91 110 124 136 167
DBP (mmHg) 100 73.5 ± 10.4 53 65 73 81 101
HR (beats/min) 100 74.0 ± 10.2 51 67 74 79 100
BAD (mm) 98 4.0 ± 0.9 2.5 3.4 3.9 4.6 6.2
FMD (%) 93 4.0 ± 5.2 –6.0 0.4 2.9 6.9 18.3
NMD (%) 47 15.2 ± 7.0 1.5 9.9 15.4 19.0 31.9
Average of 24 hourly PM2.5 (μg/m3) 98 32.1 ± 26.2 2.5 13.1 24.3 43.1 122.2
Daily average of personal PM2.5 (μg/m3) 102 18.0 ± 10.4 1.3 9.9 15.8 23.4 51.9
Daily average of ambient PM2.5 (μg/m3) 97 15.8 ± 7.6 5.9 9.9 13.0 20.4 38.9
Abbreviations: DBP, diastolic BP; Q1, 25th percentile; Q3, 75th percentile; SBP, systolic BP. Values are mean ± SD except 
where noted.Rapid effects of personal fine particulate matter
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Results
The characteristics of the total cohort (n = 51) 
of subjects enrolled during seasons 4–6 who 
had both the CV outcomes performed and 
TPE measured by continuous nephelome-
try are presented in Supplemental Material, 
Tables 1 and 2 (doi:10.1289/ehp.1002107). 
Twenty-six subjects (51%) had no self-
  reported CV disease or risk factor. Ten sub-
jects participated in two separate consecutive 
seasons; thus, there were a total of 61 sub-
ject-observation periods. Because subjects 
could contribute up to 5 consecutive days of 
data during each season, there were a total of 
265 observation days. We excluded 74 (28%) 
and 91 (34%) observations by the vest com-
pliance and low SHS rule, respectively. There 
were 38 subjects (191 observations) who 
met the 60% vest compliance rule only and 
30 (102 observations) who also met the low 
SHS rule (vest–low SHS subgroup). Table 1 
lists the characteristics of the vest–low SHS 
subgroup from which the main outcomes of 
this study are derived. The results from the 
vest-compliant group were similar to those 
from the vest–low SHS subgroup for the 
BAD and FMD outcomes (2-hr lag time) but 
not for HR changes (less significant results). 
Therefore, because of potential confounding 
effects of SHS, we proved the main results (see 
“Materials and Methods”) for the vest–low 
SHS group (Table 1).
The changes in the CV parameters per 
10 µg/m3 TPE are presented by lag time in 
hours (0–23 hr) in Figure 1 for HR, BAD, 
and FMD. It is difficult to interpret the true 
statistical significance of each time lag because 
of the many lags examined. However, we did 
observe some tendencies in the temporal pat-
tern. We observed positive associations for 
time lags of 1–10 hr for HR (0.38 to 0.78 
beats/min per 10 µg/m3) but not for the 
11–23 hr lags. We also estimated the 1–10 hr 
time lag effects with more precision (i.e., nar-
rower confidence intervals) compared with 
the longer time lags. The temporal pattern 
between TPE and either BAD and FMD was 
neither as clear nor consistent. However, we 
observed an overall trend for positive and 
negative associations for BAD and FMD, 
respectively, during the 24-hr period. The 
strongest evidence for an association was at 
the 2-hr time lag for both FMD (negative 
association) and BAD (positive association). 
We observed no consistent relationships with 
TPE (equal numbers of positive and negative 
associations) for the BP levels or for NMD 
[see Supplemental Material, Figures 1–3 
(doi:10.1289/ehp.1002107)].
Adding additional available variables to 
the model (e.g., season, visit day) did not 
affect the results. Although the general trends 
remained similar, evaluating the associations 
with longer moving averages (2–6 hr) did 
not provide further insights into the nature 
of the TPE–response relationships beyond 
the more complete information gained by 
examining the effect of each hour individually 
(data not shown). In this context, the mean 
TPE integrated over the entire preceding 
24-hr period was significantly associated only 
with an increase in HR (0.78 beats/min per 
10 µg/m3, p < 0.05). We also examined the 
interaction effects between TPE and medi-
cations in two ways: use of a beta blocker 
and use of any of the five CV medications 
Figure 1. Associations of hourly TPE levels with CV outcomes according to the lag period of exposure: 
personal PM2.5 and HR (A), BAD (B), and FMD (C). The x-axis is the period of time (hour lag) before the 
measurement of the CV outcome; hour 0 = period from 0–60 min before the CV measurement. Points indi-
cate the multivariate-adjusted CV outcome association (β-coefficient per 10-μg/m3 increase in TPE ± 95% 
confidence intervals) for each hourly time point from the linear mixed model 1. Colored data points indicate 
statistically significant time points. 
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reported [see Supplemental Material, Table 2 
(doi:10.1289/ehp.1002107)]. Because only 
three subjects in the vest–low SHS subgroup 
were using a beta blocker, we did not evalu-
ate the effects in these subjects alone. On the 
other hand, the association between TPE and 
CV outcomes remained almost the same, with 
no changes in significance, after excluding 
these three subjects. Six subjects were using 
any medication. The medication interaction 
effects for HR, BAD, and FMD were insignif-
icant, and thus the main association between 
TPE and the three CV outcomes did not 
change in significance. Finally, we observed 
no consistent findings related to subjects’ 
health status (BMI, initial HR or BP, age) 
modifying the outcome associations. Subjects 
with low CV risk (Framingham risk score 
below the mean) had positive HR associations 
similar to those of the total cohort (56 obser-
vations). Fewer subjects (27 observations) had 
risk above the mean, and thus the associations 
were not significant. The results are of unclear 
validity given the limited sample size but do 
not generally suggest that higher-risk patients 
have larger CV responses (or are principally 
responsible for the findings).
Discussion
PM2.5 exposure has been shown to be capable 
of increasing BP/HR and impairing vascu-
lar function. However, these responses have 
typically been observed to occur ≥ 1 day after 
exposures that are ≥ 24 hr in duration and 
as estimated by ambient community levels 
(Brook and Rajagopalan 2009). This is the 
first study to report the BP and HR changes 
together with the vascular responses associ-
ated with brief personal PM2.5 exposures as 
they change each hour throughout the pre-
ceding day during routine activity. Higher 
TPE levels (without source considerations) 
encountered during several periods (most con-
sistently during the most recent 11 hr) were 
related to small increases in HR. In addition, 
we observed concomitant early (lag hour 2) 
trends toward conduit artery vasodilatation 
(increased BAD) and impairment in endothe-
lial function (decreased FMD). Although 
these effects were small in size and intermit-
tently statistically significant, they did occur in 
a consistent and coherent biological manner. 
We acknowledge that this study was explor-
atory and should be considered hypothesis 
generating. Although chance statistical asso-
ciations cannot be excluded given the numer-
ous observations evaluated, and although the 
health significance must remain speculative, 
these responses (along with the underlying 
physiological pathway likely responsible) could 
help to explain the mechanism underlying 
PM2.5-mediated CV events that occur during 
the same day of exposure among susceptible 
individuals (Peters et al. 2001).
Few studies have investigated the effects 
of PM exposures within the same day on 
BP, HR, or vascular function (Chuang et al. 
2005; Dales et al. 2007; He et al. 2010; 
Langrish et al. 2009; Rundell et al. 2007). In 
the most similar previous study, both BP and 
HR increased in relation to higher personal 
ultrafine particle levels encountered during 
the previous 1–2 hr among 10 patients with 
lung disease (Chuang et al. 2005). However, 
the investigators did not examine vascular 
function, periods of exposure before 4 hr, 
or the effects of PM2.5. The study was small 
and restricted to patients with lung disease; 
therefore, its pertinence to the general popu-
lation is questionable. Four other studies have 
investigated the acute effect of brief ambient 
estimates of PM2.5 exposures (30–120 min) 
within the same day on similar CV param-
eters. However, in each report, except for 
that of He et al. (2010; see below), exposures 
were generated by artificial scenarios that con-
veyed higher concentrations than routinely 
encountered and with the responses evalu-
ated only once within minutes thereafter. 
PM has been shown to impair FMD with-
out affecting BP or HR at a bus stop (PM2.5 
~ 40 µg/m3) (Dales et al. 2007), to raise BP 
with a trend toward an increase in HR while 
walking next to city streets in Beijing (PM2.5 
~ 86–140 µg/m3) (Langrish et al. 2009), and 
to cause a decrease in BAD and FMD imme-
diately after exercising close to a roadway 
(ultrafine counts ~ 115,000–134,000 par-
ticles/cm3) (Rundell et al. 2007). Despite 
variations in specific findings (possibly due 
to multiple methodology differences), these 
studies generally support our findings and 
the hypothesis that PM could pose an imme-
diate threat to the CV system within hours 
of exposure. Our results significantly extend 
these reports by more fully characterizing the 
temporal relationships between several con-
comitantly measured CV outcomes with brief 
personal-level PM2.5 exposures encountered 
throughout the preceding full 24-hr period at 
more typical present-day ambient levels. Two 
other studies corroborate our finding that a 
more prolonged exposure (previous 24-hr-
long mean personal PM2.5 level) can cause 
a small increase in HR around 0.44–1.15 
beats/min (Liu et al. 2009; Mar et al. 2005).
In contrast to HR, we did not observe 
a coherent effect of same-day TPE levels on 
BP. This differs from some of our previous 
findings. Higher community PM2.5 levels 
measured 2–5 days earlier in three Detroit 
areas have been associated with elevations in 
BP (Dvonch et al. 2009). Integrated 24-hr 
TPE levels measured by filter-based meth-
ods from subjects participating in this CV 
substudy of DEARS averaged from approxi-
mately 8 to 32 hr before the time of BP meas-
urement were also associated with an increase 
in systolic BP (1.4 mmHg per 10-µg/m3 
increase) (Brook et al. 2010). Two other pre-
vious studies have reported a same-day effect 
of comparatively higher levels of particle expo-
sures on BP (Chuang et al. 2005; Langrish 
et al. 2009) whereas another did not (Dales 
et al. 2007). Differences in pollutant concen-
trations, characteristics, constituents, or sub-
ject susceptibilities may have been responsible 
for these discordant findings among studies. 
However, the BP elevations we twice previ-
ously observed in relation to ambient PM2.5 
levels in the same region (Detroit commu-
nities) occurred only in a delayed fashion. 
We hypothesize that, given the multitude 
of physiological parameters regulating sys-
temic arterial BP, these relatively low TPE 
concentrations may require a longer cumula-
tive duration of exposure and/or lag period in 
order to elicit an observable effect (Brook and 
Rajagopalan, 2009). On the other hand, the 
biological pathway responsible for causing an 
increase in HR may be more acutely sensitive 
to these low-level PM2.5 concentrations, or 
alternatively, small changes in chronotropic 
responses may be a more statistically discern-
ible outcome.
Potential biological mechanisms. This 
study was not designed to elucidate the 
mechanisms responsible for the observed CV 
changes. We acknowledge that any such dis-
cussion is speculative. However, we believe 
that the sum results can be interpreted to 
provide an overall hypothesis. There are three 
general pathways that could link PM2.5 expo-
sure with changes in CV physiology: systemic 
inflammation (pathway 1), altered auto-
nomic nervous system balance (pathway 2), 
and direct effects of particles or constituents 
reaching the circulation (pathway 3) (Brook 
2008). It cannot be excluded that each path-
way alone and/or as an integrated response 
altogether was responsible for the seemingly 
mixed physiological changes observed in HR, 
FMD, and BAD. However, given the rapidity 
of the responses, it is probable that pathways 2 
or 3 were chiefly involved. Although effects via 
pathway 3 cannot be excluded, given the low 
concentrations of PM2.5 it seems most plau-
sible to principally instigate pathway 2. Thus, 
we believe that acute vagal withdrawal with a 
(relative) increase in sympathetic nervous sys-
tem activity likely caused the elevation in HR.
It is also possible that pathway 2 alone 
could have caused the observed trends toward 
conduit artery vasodilatation and blunted 
endothelial function within this rapid time 
frame. There is complex interaction between 
the autonomic nervous system and vascu-
lar tone/endothelial function (Harris and 
Matthews 2004). Acute sympathetically 
mediated α-receptor–induced vasoconstric-
tion in the resistance arterioles is regionally 
discordant, occurring in mesenteric but not Rapid effects of personal fine particulate matter
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muscle beds (i.e., brachial artery) upon sym-
pathetic stimulation. In addition, a vaso-
constrictive response is blunted by a reflex 
increase in basal nitric oxide release in con-
duit vessels supplying skeletal muscles and 
by β2 receptor activation that cause vasodi-
latation (i.e., increased BAD), allowing for 
adequate muscle blood flow under periods 
of stress. Other studies also demonstrate that 
sympathetic activation subsequently leads to a 
rapid impairment within hours in stimulated 
(e.g., flow-mediated) brachial artery endothe-
lial-dependent vasodilatation (Hijmering et al. 
2002). Thus, all three outcomes observed in 
this study may have stemmed from a rapid 
imbalance of autonomic nervous system 
activity. A recent study by He et al. (2010) 
supports this speculation. He et al. (2010) 
similarly found that HR increased rapidly 
3–6 hr after elevations in personal-level PM2.5 
exposure. Moreover, HR variability metrics 
suggestive of autonomic imbalance favoring 
sympathetic tone occurred during this same 
rapid time window.
Strengths and limitations. The CV sub-
study of DEARS is the first to investigate the 
effect of air pollutants on these CV outcomes 
measured in the actual “field” (i.e., households 
of subjects). This methodology avoided the 
atypical exposures and activities that would 
occur when subjects travel to a research labo-
ratory and thereby strengthened our ability 
to observe the “real” exposure–response asso-
ciations occurring on typical days. Conducting 
personal-level PM2.5 exposure assessments 
and adjusting for the confounding effects of 
vest compliance and SHS also minimized the 
level of exposure misclassification (Rodes et al. 
2010). Such steps also improved the data qual-
ity and the proper characterization of those 
most exposed at the individual level, which 
in turn improved the power of the data con-
tent at all levels of the exposure distributions. 
These procedures strengthened our capabili-
ties to observe small health effects, as reported 
earlier (Brook et al. 2010), within a relatively 
small sample size and theoretically added sup-
port for the veracity of the health–exposure 
associations. These robust methodologies are 
critically important in order to establish expo-
sure-to-outcome linkages, particularly given 
that the composition and character of the 
PM2.5 can differ across the exposure distribu-
tion (Edwards and Jantunen 2009).
We also recognize several limitations. We 
made no attempt to examine the personal 
exposure factors or time–activity patterns of 
the participants and their potential impact 
on the health outcomes. Future investigations 
are planned that will determine the ambi-
ent and major nonambient sources encoun-
tered by participants in various locations as 
well as their impact on significant health out-
comes. The study was also not designed to 
assess the associations between hourly TPE 
levels and the CV outcomes. The exploratory 
nature and multiple comparisons performed 
in this analysis make it possible that some of 
the significant results represent chance find-
ings. However, we believe that the consistent 
effects on HR within the first 11 hr and the 
coherency of the trends of effects for BAD 
and FMD throughout the monitoring period 
suggest that true biological responses are likely 
occurring. It is possible that having more 
observations would have provided additional 
power and that many of the borderline non-
significant time points in the BAD and FMD 
trends would have become statistically signifi-
cant. Future appropriately designed and pow-
ered studies are required to corroborate these 
novel findings. The ultrasound measurements 
were also performed at the subject’s house-
hold. Although standardized methodologies 
and subject preparation were carefully fol-
lowed (Brook et al. 2005), the reproducibility 
of the FMD and BAD may have been less 
than what can be obtained in a vascular labo-
ratory. However, we believe that the overall 
strengths of this design (i.e., performing the 
studies in the actual “field”) outweighed this 
limitation. The statistical significance of the 
small changes observed for HR, BAD, and 
FMD suggests that the sample size using these 
methods was adequate. Finally, regarding 
the vascular responses, we observed a trend 
toward an increase in the basal BAD dur-
ing the time period analyzed. A larger initial 
BAD could mathematically produce a smaller 
FMD response when the latter is expressed as 
a percent dilatation from baseline. We cannot 
exclude that this may have contributed to a 
decrease in FMD (percentage), and future 
studies should therefore analyze both the per-
cent and absolute (in millimeters) vasodilatory 
responses when basal diameter (i.e., resting 
arterial tone) may be altered.
Although the main DEARS protocol 
sampled a random representation of the local 
residents, the findings from this substudy 
may not generalize to the entire population. 
However, compared with previous similar 
studies, the participants in this analysis repre-
sented a relatively larger cohort of individuals 
with a broader range of health conditions. 
Although we performed exploratory analy-
ses regarding potential effect modifiers (e.g., 
medications, demographics), further investi-
gation related to the effects of patient suscep-
tibilities is warranted. Finally, the responsible 
PM2.5 components and sources could not 
be determined from these data. We also did 
not have hourly personal-level gaseous pol-
lutant information, and there is a possibility 
for unrecognized additional, or confound-
ing, effects of these copollutants. Ongoing 
and planned analyses may help provide future 
insights into these important matters.
Conclusions
Higher TPE levels encountered during 
routine daily activity were related to small 
increases in HR and trends toward endothe-
lial dysfunction within hours of exposure 
among individuals living in several Detroit-
area communities. Although the clinical rele-
vance of these responses remains unknown, 
the findings support in general the notion 
that present-day levels of PM2.5 could poten-
tially rapidly affect CV physiology in a man-
ner contributing to the instigation of acute 
CV events in susceptible people.
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